Cycle Pharmaceuticals has launched Cycle Vita PKU, an AI-powered app to help patients with PKU manage every aspect of their treatment plan.
Health Technology Insights: bioAffinity Boosts CyPath Lung Test Speed and Cuts Costs
PKU is an inherited disorder caused by a deficiency of the phenylalanine hydroxylase (PAH) enzyme needed to process phenylalanine (Phe), which is found in all foods containing protein.1 Nearly all cases of PKU are diagnosed through newborn screenings, and require lifelong adherence to a strict PKU diet.3
It can be challenging for patients with PKU, or their caregivers, to keep on top of everything, like medication, medical formula, lab results and diet. The app is designed to offer flexible and timely support with daily tracking, reminders and diet management tools. Users can plan their meals with a searchable food database of over 9,000 foods, as well as an AI-powered meal scanner that estimates Phe levels with a photo snap of the meal.
Health Technology Insights: Instem Expands Preclinical Platform for Regulatory Needs
For adolescents and young adults, who are gaining independence and navigating the transition to adulthood, Cycle Vita PKU may be a helpful aid for adhering to their medication and a Phe-restricted diet on-the-go.
“The launch of Cycle Vita PKU marks an exciting milestone as the first app from Cycle Vita, Cycle’s dedicated patient support platform. As part of Cycle’s commitment to the PKU community, Cycle will continue to innovate and find new ways to provide support tailored to patients’ needs. Cycle Vita PKU is just one example of that commitment.” says Jamie Ray, Director – Patient Support Program, Cycle.
Cycle Vita PKU does not provide medical advice, diagnosis or treatment. Always seek the advice of your healthcare provider with any questions you may have.
Health Technology Insights: MDVIP Expands in Austin with Two New Primary Care Practices
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
